Key result
HuR inhibition limits remodeling and preserves post-ischemia cardiac function by dampening inflammation.
Why the study?
HuR reduces cardiac remodeling after myocardial infarction and pressure overload, but the full extent of HuR-dependent mechanisms in myocardial cells remains to be elucidated.
HuR inhibition at the time of reperfusion reduces post-ischemic adverse cardiac remodeling by dampening early cardiomyocyte-derived inflammatory signaling and subsequent macrophage recruitment.
HuR inhibition at reperfusion may limit remodeling in mice; hypothesis-generating for clinical translation in human ischemia/reperfusion injury.
The RNA-binding protein human antigen R (HuR) has been shown to reduce cardiac remodeling following both myocardial infarction and cardiac pressure overload, but the full extent of the HuR-dependent mechanisms within cells of the myocardium has yet to be elucidated. Wild-type mice were subjected to 30 min of cardiac ischemia (via LAD occlusion) and treated with a novel small molecule inhibitor of HuR at the time of reperfusion, followed by direct in vivo assessment of cardiac structure and function. Direct assessment of HuR-dependent mechanisms was done in vitro using neonatal rat ventricular myocytes (NRVMs) and bone marrow-derived macrophages (BMDMs). HuR activity is increased within 2 h after ischemia/reperfusion (I/R) and is necessary for early post-I/R inflammatory gene expression in the myocardium. Despite an early reduction in inflammatory gene expression, HuR inhibition has no effect on initial infarct size at 24 h post-I/R. However, pathological remodeling is reduced with preserved cardiac function at 2 weeks post-I/R upon HuR inhibition. RNA sequencing analysis of gene expression in NRVMs treated with LPS to model damage-associated molecular pattern (DAMP)-mediated activation of toll-like receptors (TLRs) demonstrates a HuR-dependent regulation of pro-inflammatory chemokine and cytokine gene expression in cardiomyocytes. Importantly, we show that conditioned media transfer from NRVMs pre-treated with HuR inhibitor loses the ability to induce inflammatory gene expression and M1-like polarization in bone marrow-derived macrophages (BMDMs) compared to NRVMs treated with LPS alone. Functionally, HuR inhibition reduces macrophage infiltration to the post-ischemic myocardium in vivo. Additionally, we show that LPS-treated NRVMs induce the migration of peripheral blood monocytes in a HuR-dependent endocrine manner. These studies demonstrate that HuR is necessary for early pro-inflammatory gene expression in cardiomyocytes following I/R injury that subsequently mediates monocyte recruitment and macrophage activation in the post-ischemic myocardium.
No takes yet. Share an insight, caveat, or question.
Slone et al. (2025) studied Cardiac ischemia/reperfusion injury. Small molecule inhibitor of HuR was evaluated on Pathological remodeling and cardiac function. HuR inhibition reduced pathological remodeling and preserved cardiac function at 2 weeks post-ischemia/reperfusion by dampening myocyte-dependent inflammatory gene expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: